Medications for Hiv1
50 results
Abacavir sulfate, lamivudine and zidovudine (abacavir sulfate, lamivudine and zidovudine)
(ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE)LUPIN LIMITED
Usage: Abacavir, lamivudine, and zidovudine tablets are indicated for the treatment of HIV-1 infection, either alone or in combination with other antiretrovirals. However, there is limited data on its effectiveness in patients with high baseline viral load (over 100,000 copies/mL).
Apretude (cabotegravir)
(Cabotegravir)ViiV Healthcare Company
Usage: APRETUDE is indicated for pre-exposure prophylaxis (PrEP) to decrease the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are at risk. A negative HIV-1 test is required before starting APRETUDE.
Atripla (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)
(efavirenz, emtricitabine, and tenofovir disoproxil fumarate)Gilead Sciences Inc
Usage: ATRIPLA® is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg, either as a complete regimen or in combination with other antiretroviral agents.
Atripla (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)
(efavirenz, emtricitabine, and tenofovir disoproxil fumarate)Physicians Total Care, Inc.
Usage: ATRIPLA® is indicated for the treatment of HIV-1 infection in adults and pediatric patients aged 12 and older, either as a complete regimen or in combination with other antiretroviral agents.
Biktarvy (bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate)
(bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate)Gilead Sciences Inc
Usage: BIKTARVY is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 14 kg, either as a complete regimen for those without prior antiretroviral treatment history or to replace a stable regimen in virologically-suppressed patients without known resistance.
Complera (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate)
(emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate)Gilead Sciences Inc
Usage: COMPLERA® is indicated for treating HIV-1 in adults and pediatric patients (≥35 kg) as initial therapy for those with HIV-1 RNA ≤100,000 copies/mL or to replace a stable regimen in virologically suppressed patients (HIV-1 RNA <50 copies/mL) without known drug resistance.
Darunavir (darunavir)
(Darunavir)Amneal Pharmaceuticals NY LLC
Usage: Darunavir, when combined with ritonavir and other antiretroviral agents, is indicated for the treatment of HIV-1 infection in patients aged 3 years and older.
Delstrigo (doravirine, lamivudine, and tenofovir disoproxil fumarate)
(doravirine, lamivudine, and tenofovir disoproxil fumarate)Merck Sharp & Dohme LLC
Usage: DELSTRIGO® is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg, either as a complete regimen for those with no prior antiretroviral treatment history or to replace the current regimen in patients who are virologically suppressed.
Dovato (dolutegravir sodium and lamivudine)
(dolutegravir sodium and lamivudine)ViiV Healthcare Company
Usage: DOVATO is indicated for the treatment of HIV-1 infection in adults and adolescents (ages 12 and older, weighing at least 25 kg) with no prior antiretroviral therapy or to replace the current regimen in those who are virologically suppressed without resistance concerns.
Edurant (rilpivirine hydrochloride)
(rilpivirine hydrochloride)Janssen Products, LP
Usage: EDURANT is indicated for the treatment of HIV-1 in treatment-naïve patients aged 2 years and older weighing at least 14 kg with HIV-1 RNA ≤100,000 copies/mL. It is also used in combination with cabotegravir for short-term treatment in virologically suppressed patients aged 12 years and older.